What Tripped Up Ambarella’s Q2

Photo of Chris Lange
By Chris Lange Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
What Tripped Up Ambarella’s Q2

© Thinkstock

When Ambarella Inc. (NASDAQ: AMBA) released its fiscal second-quarter financial results after the markets closed on Thursday, the fabless semiconductor design company said that it had $0.25 in earnings per share (EPS) and $62.5 million in revenue. The consensus estimates had called for $0.13 in EPS on revenue of $62.3 million. In the same period of last year, it said it had EPS of $0.56 and $71.6 million in revenue.

During the most recent quarter, the gross margin was 61.4%, compared with 63.0% for the same period in the previous fiscal year.

On the books, Ambarella’s cash and cash equivalents totaled $295.3 million at the end of the quarter, down from $346.7 million at the end of the previous fiscal year.

Looking ahead to the fiscal third quarter, the company expects to see revenue between $55.5 million and $58.5 million, with a gross margin of 59.0% to 60.5%. Consensus estimates call for $0.29 in EPS and $72.0 million in revenue for the quarter.

[nativounit]

Fermi Wang, president and CEO, commented:

While we are disappointed with our near term outlook, we remain confident that our decision to focus on computer vision applications in the IP security, automotive and robotics AI markets is the correct strategy and is already bearing fruit. We have delivered our CV22 and CV2 computer vision chips to customers and their evaluation results are very encouraging. We believe our excellent neural network processing performance combined with the low power of our solutions gives us a strong competitive position in our target markets. Moreover, we continue to expand our computer vision product family to deliver solutions that more fully address the growing market opportunity.

Shares of Ambarella traded down 8.7% early Friday at $36.29, with a consensus analyst price target of $53.89 and a previous 52-week range of $37.10 to $66.23.

[recirclink id=488498]

[wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Our $500K AI Portfolio

See us invest in our favorite AI stock ideas for free

Our Investment Portfolio

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618